Baird Medical Secures Product Registrations in Pakistan and Vietnam
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 07 2026
0mins
Source: PRnewswire
- Regulatory Milestone: Baird Medical has successfully obtained official product registrations from both the Medical Device Board of Pakistan and the Ministry of Health of Vietnam, marking the legalization of its Microwave Ablation technology in these markets, which is expected to drive the company's expansion in the Asia-Pacific region.
- Market Access: This registration not only allows Baird Medical to legally sell its products in Pakistan and Vietnam but also enhances its competitiveness in the rapidly growing medical device market, further boosting brand influence.
- Strategic Positioning: By securing product registrations in these two countries, Baird Medical solidifies its strategic positioning in the Asia-Pacific region, which is anticipated to lay the groundwork for future sales growth and market share enhancement.
- Technology Promotion: With the completion of product registrations, Baird Medical will be able to accelerate the market promotion of its Microwave Ablation technology, addressing local healthcare needs and driving overall performance improvements for the company.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BDMD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BDMD
About BDMD
Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Baird Medical Successfully Concludes Gynecological Microwave Ablation Masterclass in Shanghai
- Effective Training: Baird Medical's Gynecological Microwave Ablation Masterclass in Shanghai attracted numerous physicians from Asia, enhancing their expertise in treating benign gynecological conditions through a curriculum that combines theory and practical application, thus promoting the adoption of minimally invasive treatments.
- In-Depth Technology Application: Led by Dr. Xiaoming Gong of Weheal, the event featured expert lectures and live case observations, providing participants with critical insights into clinical applications and techniques, thereby enhancing the clinical practice capabilities of regional physicians.
- Market Leadership Reinforced: Baird Medical maintains its leading position in the thyroid microwave ablation device market in China, and this Masterclass further solidifies its market influence in minimally invasive healthcare, laying the groundwork for future business expansion.
- Global Strategic Layout: The company is committed to promoting its minimally invasive treatment products in over 20 countries worldwide, fostering strategic collaborations with leading academic institutions to drive technological innovation and market expansion, ultimately improving patient treatment outcomes.
Continue Reading
Baird Medical Successfully Concludes Gynecological Microwave Ablation Masterclass in Shanghai
- Successful Training: Baird Medical successfully concluded its Gynecological Microwave Ablation Masterclass in Shanghai, led by Dr. Xiaoming Gong of Weheal, aimed at enhancing procedural expertise in treating benign gynecological conditions, thereby reinforcing the company's leadership in minimally invasive technology.
- Rigorous Curriculum: The program offered a comprehensive curriculum focused on the application of the company's proprietary technology for microwave ablation, ensuring participants master the latest medical techniques to improve patient treatment outcomes and satisfaction.
- Market Leadership: By hosting this masterclass, Baird Medical not only showcased its expertise in microwave ablation technology but also strengthened partnerships with healthcare institutions, further expanding its market influence.
- Future Growth Potential: The successful execution of this event signifies the company's ongoing commitment to education and training, which is expected to lay a solid foundation for future business growth and technology dissemination.
Continue Reading